Literature DB >> 14648152

MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension.

Tünde Csépány1, Dániel Bereczki, József Kollár, Judit Sikula, Emese Kiss, László Csiba.   

Abstract

Involvement of the brain is one of the most important complications of systemic lupus erythematosus (SLE). To investigate the correlation between abnormal cranial MRI findings and age, duration of SLE, neuropsychiatric (NP) manifestations, hypertensive status, and the presence of antiphospholipid antibodies (PA) in patients with SLE we evaluated the MRI results of 81 SLE patients in nine NP clinical subgroups.Immunoserological status was described by the presence of lupus anticoagulant (LA), and anticardiolipin antibodies (aCL). The MRI findings were categorized as normal [41], cerebral atrophy [15], small subcortical hyperintensity [7], and infarct larger than 10mm [18]. Mean age differed among the clinical subgroups (ANOVA, p = 0.002), whereas there was no age difference among the subgroups based on MRI and immunoserological results. Patients with hypertension (33/81) were a mean of 6 years older at the time of examination (p = 0.033) and had stroke more frequently, than normotensive ones (p = 0.0015). MRI abnormalities were more frequent in patients with LA positivity (p < 0.01) than in those without these antibodies, and in the hypertensive than in the normotensive subgroup (p = 0.00041). The presence of PA was associated with abnormal MRI even after controlling for the effect of age and hypertensive status (p = 0.011). In our study the MRI findings in central nervous system SLE were independent of the age of patients and the age at the diagnosis of SLE, and were not influenced by the duration of SLE; however, they were associated with immunoserological parameters and hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648152     DOI: 10.1007/s00415-003-0223-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

Review 1.  Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.

Authors:  George K Bertsias; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

Review 2.  Antiphospholipid antibodies in young adults with stroke.

Authors:  Robin L Brey
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

3.  Episodic memory impairment in systemic lupus erythematosus: involvement of thalamic structures.

Authors:  Nicolle Zimmermann; Diogo Goulart Corrêa; Tania Maria Netto; Tadeu Kubo; Denis Batista Pereira; Rochele Paz Fonseca; Emerson Leandro Gasparetto
Journal:  Clin Rheumatol       Date:  2015-01-10       Impact factor: 2.980

4.  Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus.

Authors:  Rex E Jung; Judith M Segall; Rachael G Grazioplene; Clifford Qualls; Wilmer L Sibbitt; Carlos A Roldan
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

5.  Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.

Authors:  Michelle Petri; Mohammad Naqibuddin; Kathryn A Carson; Daniel J Wallace; Michael H Weisman; Stephen L Holliday; Margaret Sampedro; Shalini Narayana; Peter T Fox; Crystal Franklin; Patricia A Padilla; Robin L Brey
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

6.  Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.

Authors:  Zhen Tan; Yingbo Zhou; Xiangpei Li; Guosheng Wang; Jinhui Tao; Li Wang; Yan Ma; Xiaomei Li
Journal:  Clin Rheumatol       Date:  2017-11-04       Impact factor: 2.980

Review 7.  Neurologic manifestations of the antiphospholipid syndrome.

Authors:  Jose F Roldan; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

8.  Early cerebral volume reductions and their associations with reduced lupus disease activity in patients with newly-diagnosed systemic lupus erythematosus.

Authors:  Anselm Mak; Roger Chun-Man Ho; Han-Ying Tng; Hui Li Koh; Joanna Su Xian Chong; Juan Zhou
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

9.  Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.

Authors:  Stefan C A Steens; Gerlof P T H Bosma; Gerda M Steup-Beekman; Saskia le Cessie; Tom W J Huizinga; Mark A van Buchem
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

Review 10.  Advanced and Conventional Magnetic Resonance Imaging in Neuropsychiatric Lupus.

Authors:  Nicolae Sarbu; Núria Bargalló; Ricard Cervera
Journal:  F1000Res       Date:  2015-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.